← Back to Search

Behavioral Intervention

Brain Training for Breast Cancer Survivors

N/A
Recruiting
Led By Sandra B Chapman, PhD
Research Sponsored by The University of Texas at Dallas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female breast cancer survivors who are between ages of 30-80
Female breast cancer survivors who received chemotherapy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 month, 6 month
Awards & highlights

Study Summary

This trial will test if online cognitive exercises can help improve brain health and performance in breast cancer survivors who have reported changes in thinking since treatment.

Who is the study for?
This study is for female breast cancer survivors aged 30-80 who have completed chemotherapy between 6 months and 5 years ago, are fluent in English, and feel their thinking has changed since treatment. Participants need internet access and a device to join the online training but can't join if they've had brain injuries post-chemotherapy, substance abuse issues, certain neurological or psychotic disorders, recent cognitive training, or severe hearing/vision problems.Check my eligibility
What is being tested?
The trial explores three different online brain health trainings (A, B, C) designed to help improve cognitive function in breast cancer survivors experiencing 'brain fog' after chemotherapy. The effectiveness of each method will be compared to see which one offers the most benefit.See study design
What are the potential side effects?
Since this trial involves non-invasive brain training exercises conducted online rather than medication or medical procedures, there are no direct physical side effects associated with participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a female breast cancer survivor aged between 30 and 80.
Select...
I am a female breast cancer survivor who received chemotherapy.
Select...
I am a female breast cancer survivor and I consider myself fluent in English.
Select...
I am a breast cancer survivor noticing changes in my thinking since chemotherapy.
Select...
I finished my breast cancer chemotherapy between 6 months and 5 years ago.
Select...
I am a female breast cancer survivor, diagnosed at Stage I-III.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 month, 6 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 month, 6 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
BrainHealth Index Score
Secondary outcome measures
Functional Assessment of Cancer Therapy - Cognitive Function (FACT_Cog)

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Brain Training AExperimental Treatment1 Intervention
This group will access one type of online brain-health oriented training.
Group II: Brain Training BActive Control1 Intervention
This group will access a distinct type of online brain-health oriented training.
Group III: Brain Training CActive Control1 Intervention
This group will access a distinct type of online brain-health oriented training.

Find a Location

Who is running the clinical trial?

The University of Texas at DallasLead Sponsor
58 Previous Clinical Trials
106,072 Total Patients Enrolled
Sandra B Chapman, PhDPrincipal InvestigatorCenter for BrainHealth
1 Previous Clinical Trials
100,000 Total Patients Enrolled

Media Library

Strategic Memory Advanced Reasoning Training (SMART) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05444231 — N/A
Breast Cancer Research Study Groups: Brain Training A, Brain Training B, Brain Training C
Breast Cancer Clinical Trial 2023: Strategic Memory Advanced Reasoning Training (SMART) Highlights & Side Effects. Trial Name: NCT05444231 — N/A
Strategic Memory Advanced Reasoning Training (SMART) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05444231 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is eligibility for this experiment restricted to those over 30 years of age?

"The required age range for this trial is 28 to 80, as stated by the inclusion criteria."

Answered by AI

Is there an opportunity for me to participate in this research project?

"This clinical trial is recruiting two hundred female patients aged 28 to 80 with a diagnosis of stages I-III breast cancer. Eligibility criteria include being literate in English, having had chemotherapy within the past 5 years to 6 months (if applicable), and access to audio/visual technology via an Internet connection and device."

Answered by AI

What is the ceiling for patient involvement in this clinical trial?

"Affirmative. Evidently, clinicaltrials.gov has published the details of this investigation which first appeared on June 1st 2022 and was modified a few weeks ago on June 29th 2022. This study is intending to enlist 200 people from one location for participation in their research trial."

Answered by AI

Are there still vacancies for involvement in this medical experiment?

"The data hosted on clinicaltrials.gov confirms that this medical research is actively seeking new participants; the project was first added to the website on June 1st, 2022 and was modified most recently on June 29th, 2022."

Answered by AI
Recent research and studies
~78 spots leftby Jun 2025